NCT01287637

Brief Summary

The study is being conducted as a prospective randomized controlled multicenter study of patients with a temporary ileostomy due to rectal cancer. The study will be conducted in hospitals in Denmark and Sweden under the framework of the Scandinavian Surgical Outcomes Group (www.ssorg.net). The study investigates the effect of reversing a temporary ileostomy after 8-13 days instead of later reversal more than 12 weeks after surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
89

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 28, 2011

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 1, 2011

Completed
Same day until next milestone

Study Start

First participant enrolled

February 1, 2011

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

January 20, 2016

Status Verified

January 1, 2016

Enrollment Period

4.8 years

First QC Date

January 28, 2011

Last Update Submit

January 16, 2016

Conditions

Keywords

Rectal cancerTemporary ileostomyEaly reversalMorbidityMortalityQuality of lifeEconomic effect

Outcome Measures

Primary Outcomes (3)

  • Postsurgical morbidity

    Patients are scored according to the Clavien-Dindo Classification of Surgical Complications.

    3 months after inclusion

  • Postsurgical morbidity

    Patients are scored according to the Clavien-Dindo Classification of Surgical Complications.

    6 months after inclusion

  • Postsurgical morbidity.

    Patients are scored according to the Clavien-Dindo Classification of Surgical Complications.

    12 months after inclusion-

Secondary Outcomes (5)

  • Quality of life

    Quality of life is assessed at 3 months after inclusion

  • Quality of life

    Quality of life is assessed at 6 months after inclusion

  • Quality of life

    Quality of life is assessed at 12 months after inclusion

  • Socio-economic effect of early reversal of temporary ileostomy

    The investigators assess and analyze the economic effect 6 months after inclusion

  • Socio-economic effect of early reversal of temporary ileostomy

    The investigators assess and analyze the economic effect 12 months after inclusion

Study Arms (2)

Early reversal group

EXPERIMENTAL

Early reversal of temporary ileostomy

Procedure: Early reversal of temporary ileostomy

Control group

ACTIVE COMPARATOR

Standard reversal of temporary ileostomy

Procedure: Standard reversal of temporary ileostomy

Interventions

Temporary ileostomy is reversed 8-13 days after the primary surgery

Also known as: stoma reversal 8-13 days post surgery
Early reversal group

Patients in the control group will have the ileostomy reversed according to standard treatment, which is 12-26 weeks after primary operation

Also known as: stoma reversal 12-26 weeks after stoma creation
Control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with a temporary ileostomy after low anterior resection because of rectal cancer
  • Patients, who are physically and mentally fit to undergo surgery within 8-13 days

You may not qualify if:

  • Patients whose stoma is not reversible
  • Patients with diabetes
  • Patients being treated with Steroids
  • Patients with communicative problems
  • Patients with expected compliance issues

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Herlev Hospital, University of Copenhagen

Herlev, 2730, Denmark

Location

Related Publications (4)

  • Park J, Angenete E, Bock D, Correa-Marinez A, Danielsen AK, Gehrman J, Haglind E, Jansen JE, Skullman S, Wedin A, Rosenberg J. Cost analysis in a randomized trial of early closure of a temporary ileostomy after rectal resection for cancer (EASY trial). Surg Endosc. 2020 Jan;34(1):69-76. doi: 10.1007/s00464-019-06732-y. Epub 2019 Mar 25.

  • Park J, Danielsen AK, Angenete E, Bock D, Marinez AC, Haglind E, Jansen JE, Skullman S, Wedin A, Rosenberg J. Quality of life in a randomized trial of early closure of temporary ileostomy after rectal resection for cancer (EASY trial). Br J Surg. 2018 Feb;105(3):244-251. doi: 10.1002/bjs.10680. Epub 2017 Nov 23.

  • Danielsen AK, Park J, Jansen JE, Bock D, Skullman S, Wedin A, Marinez AC, Haglind E, Angenete E, Rosenberg J. Early Closure of a Temporary Ileostomy in Patients With Rectal Cancer: A Multicenter Randomized Controlled Trial. Ann Surg. 2017 Feb;265(2):284-290. doi: 10.1097/SLA.0000000000001829.

  • Danielsen AK, Correa-Marinez A, Angenete E, Skullmann S, Haglind E, Rosenberg J; SSORG (Scandinavian Outcomes Research Group). Early closure of temporary ileostomy--the EASY trial: protocol for a randomised controlled trial. BMJ Open. 2011 Jul 29;1(1):e000162. doi: 10.1136/bmjopen-2011-000162.

MeSH Terms

Conditions

Rectal Neoplasms

Interventions

Postoperative Period

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal Diseases

Intervention Hierarchy (Ancestors)

Perioperative PeriodSurgical Procedures, OperativePatient CareHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Jacob Rosenberg, Professor

    Herlev Hospital, University of Copenhagen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Nurse

Study Record Dates

First Submitted

January 28, 2011

First Posted

February 1, 2011

Study Start

February 1, 2011

Primary Completion

November 1, 2015

Study Completion

December 1, 2015

Last Updated

January 20, 2016

Record last verified: 2016-01

Locations